First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 2.05 USD 7.33% Market Closed
Updated: May 16, 2024

ATAI Life Sciences NV
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Cash from Financing Activities Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Cash from Financing Activities
-$8.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash from Financing Activities
-€679m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
Merck KGaA
XETRA:MRK
Cash from Financing Activities
-€1.7B
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
-5%
MPH Health Care AG
XETRA:93M1
Cash from Financing Activities
-€3.2m
CAGR 3-Years
30%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash from Financing Activities
€204.5m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cash from Financing Activities
-€12.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Cash from Financing Activities?
Cash from Financing Activities
-8.4m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash from Financing Activities amounts to -8.4m USD.